Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
CPT: Pharmacometrics & Systems Pharmacology|May 6, 2022
Predicting disease activity in patients with multiple sclerosis: An explainable machine-learning approach in the Mavenclad trialsSreetama Basu, Alain Munafo, Ali-Frederic Ben-Amor, et al.
British Journal of Clinical Pharmacology|June 4, 2021
Relevance of primary lesion location, tumour heterogeneity and genetic mutation demonstrated through tumour growth inhibition and overall survival modelling in metastatic colorectal cancerDiego Vera-Yunca, Zinnia P Parra-Guillen, Pascal Girard, et al.
European Journal of Cancer (Oxford, England : 1990)|November 16, 2010
A model of vascular tumour growth in mice combining longitudinal tumour size data with histological biomarkersBenjamin Ribba, Emmanuel Watkin, Michel Tod, et al.
The European Journal of Neuroscience|September 1, 2025
Frequency Coding of Multisensory Integration in the Local Field Potentials of the Medial PulvinarAnne-Laure Vittek, Cécile Juan, Corentin Gaillard, et al.
The AAPS Journal|March 19, 2020
Machine Learning Analysis of Individual Tumor Lesions in Four Metastatic Colorectal Cancer Clinical Studies: Linking Tumor Heterogeneity to Overall SurvivalDiego Vera-Yunca, Pascal Girard, Zinnia P Parra-Guillen, et al.
Clinical Pharmacology and Therapeutics|August 12, 2024
Model-informed Evidence for Clinical Non-inferiority of Every-2-Weeks Versus Standard Weekly Dosing Schedule of Cetuximab in Metastatic Colorectal CancerAna-Marija Milenković-Grišić, Siobhán Hayes, Colm Farrell, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 7, 2021
Symmetry Processing in the Macaque Visual CortexPauline Audurier, Yseult Héjja-Brichard, Vanessa De Castro, et al.
Neuroimage|February 23, 2023
Towards an optimization of functional localizers in non-human primate neuroimaging with (fMRI) frequency-taggingMarie-Alphée Laurent, Pauline Audurier, Vanessa De Castro, et al.
The Prostate|May 29, 2009
Prognostic value of modeled PSA clearance on biochemical relapse free survival after radical prostatectomyBenoit You, Pascal Girard, Philippe Paparel, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 19, 2022
Designing phase I oncology dose escalation using dose-exposure-toxicity models as a complementary approach to model-based dose-toxicity modelsKristyn Pantoja, Shankar Lanke, Alain Munafo, et al.
Pageof 9